about
Non-pharmacological measures for preventing opportunistic infection in patients with haematological malignanciesBlastoschizomyces capitatus infection in patients with leukemia: report of 26 casesVirulence and thrombocyte affectation of two Aspergillus terreus isolates differing in amphotericin B susceptibility.Identification of Aspergillus fumigatus Surface Components That Mediate Interaction of Conidia and Hyphae With Human Platelets.Overall survival and fungal infection-related mortality in patients with invasive fungal infection and neutropenia after myelosuppressive chemotherapy in a tertiary care centre from 1995 to 2006Epidemiology of invasive fungal infections in the mediterranean areaNovel antifungal drugs against fungal pathogens: do they provide promising results for treatment?Invasive fungal sinusitis in patients with hematological malignancy: 15 years experience in a single university hospital in Taiwan.Recommendations for Risk Categorization and Prophylaxis of Invasive Fungal Diseases in Hematological Malignancies: A Critical Review of Evidence and Expert Opinion (TEO-4).Management of infectious complications in the hematopoietic stem cell transplant recipient.The role of complement in invasive fungal infections.Levels of total fungus and Aspergillus on a pediatric hematopoietic stem cell transplant unit.Cytokines and fungal infections.Contribution of the Platelia Candida-specific antibody and antigen tests to early diagnosis of systemic Candida tropicalis infection in neutropenic adults.Impact of cyclosporine levels on the development of acute graft versus host disease after reduced intensity conditioning allogeneic stem cell transplantation.Rhabdomyolysis Following Initiation of Posaconazole Use for Antifungal Prophylaxis in a Patient With Relapsed Acute Myeloid Leukemia: A Case Report.Epidemiology and outcome of Rhodotorula infection in haematological patients.Cost benefit and cost effectiveness of antifungal prophylaxis in immunocompromised patients treated for haematological malignancies: reviewing the available evidence.Immunotherapy against invasive mold infections.New insight into amphotericin B resistance in Aspergillus terreus.Efficacy and toxicity of intermediate-dose amphotericin B lipid complex as a primary or salvage treatment of fungal infections in patients with hematological malignancies.Empirical antifungal therapy in patients with neutropenia and persistent or recurrent fever of unknown origin.Brief report: practicability and safety of amphotericin B deoxycholate as continuous infusion in neutropenic patients with hematological malignancies.Impact of Epstein Barr virus-related complications after high-risk allo-SCT in the era of pre-emptive rituximab.Geotrichum capitatum septicemia in patients with acute myeloid leukemia. Report of three cases.Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: an European Organisation for Research and Treatment of Cancer study.Lower respiratory tract respiratory virus infections increase the risk of invasive aspergillosis after a reduced-intensity allogeneic hematopoietic SCT.Filamentous fungi in a tertiary care hospital: environmental surveillance and susceptibility to antifungal drugs.ABO mismatch increases transplant-related morbidity and mortality in patients given nonmyeloablative allogeneic HPC transplantation.Invasive pulmonary aspergillosis in neutropenic patients and the influence of hospital renovation.The Role of IL-17 in Protection against Mucosal Candida Infections.Airborne fungus exposure prior to hospitalisation as risk factor for mould infections in immunocompromised patients.Invasive fungal infection in children undergoing chemotherapy for cancer.Invasive fungal infections in allogeneic and autologous stem cell transplant recipients: a single-center study of 166 transplanted patients.Invasive aspergillosis localised to the colon presenting as toxic megacolon.Primary gastrointestinal aspergillosis after autologous peripheral blood progenitor cell transplantation: an unusual presentation of invasive aspergillosis.
P2860
Q24193921-92BE3181-A070-407A-A627-C6A864E910C1Q28239042-BCA5472E-8A21-45DD-914C-788DA420454FQ33408090-432E7BD9-5C24-4EED-A930-77EA32D1BFECQ33421462-AFA23111-D981-4ABF-882D-CDD5A11EEF1DQ33723583-EE4BFEBA-540E-40B5-B709-1171225039A2Q35010686-014D923B-83C6-49ED-8C6A-DC8A520E7521Q35220799-9D95B85B-F696-4B24-8CAE-6E891314E177Q35386894-A76B9D0B-8328-4544-BCFB-7851484E4AF4Q35672258-7CC5B420-074C-41E5-9AF5-2F6DB92765E5Q35675979-4B075CA1-B00E-425B-ABEB-C35094FB9911Q35743823-03B9AE59-E59A-4DF2-9E1C-2F8AF715DAB2Q35763847-0FC12D1A-9725-482C-9DEE-6B8C7E63A587Q36139494-8AAD334A-B9D6-46FA-BC6F-4F6D3BD069C5Q36892250-CC59E41D-41C5-4317-8C77-7B02D1129AA0Q37592994-8C14602A-5DA8-42A8-8698-18C000BBF0C3Q37632299-451530A8-EC82-44B2-BEBE-A187E4D5B8F7Q37718939-AB240240-5E4D-40E4-B298-E60C78610D28Q37886974-96D2FEE8-33EC-42A3-A6CA-94C4284DB920Q37965757-756B8336-9B40-44F6-B21E-C104F5C4C0A8Q39767448-05938296-B4F3-49BB-9DEC-EFEBE40DC683Q40384862-24A14B5D-B71A-40C7-8D99-A4E2CD16612AQ40489288-9ED0144B-B6B1-4912-818E-6A5AB1987E5CQ40501860-0470FF28-77BA-42CE-9610-B768183AAADCQ41549338-A764AEEB-5749-4450-9D64-144AEF9FB527Q42838585-6002E968-DDFC-4E3A-91A1-08872C8E76FBQ43198289-3B82D03A-3D0B-4A6C-94F1-8A5FABD66D1CQ45385030-CFE316A2-82E3-4281-B96A-244D471244CCQ46362922-DF939F48-7E4E-4476-8BDA-6FA99C43FB8DQ47752542-287940AB-60C9-4430-B5D7-AB68B07750F0Q47930062-C3864F94-4083-4E42-BF36-027E9D3D43CEQ49184561-82A7BB71-7535-46E5-B846-3A8BF90FA75EQ51018471-94F02C71-37A7-496C-A4C0-4EF253E13DC3Q51185578-8CAE77D8-AFEE-49BA-A6F2-0850F3390827Q51185737-9054A531-A186-47B5-AA10-CF17EFCA8493Q53497098-33330AC2-8069-400A-B9AE-4980DA48890CQ54578659-482FE610-6190-49C5-9A81-FD34E6CC31BD
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Invasive fungal infections in hematology: new trends.
@ast
Invasive fungal infections in hematology: new trends.
@en
Invasive fungal infections in hematology: new trends.
@nl
type
label
Invasive fungal infections in hematology: new trends.
@ast
Invasive fungal infections in hematology: new trends.
@en
Invasive fungal infections in hematology: new trends.
@nl
prefLabel
Invasive fungal infections in hematology: new trends.
@ast
Invasive fungal infections in hematology: new trends.
@en
Invasive fungal infections in hematology: new trends.
@nl
P1433
P1476
Invasive fungal infections in hematology: new trends.
@en
P2093
P304
P356
10.1007/S00277-002-0466-3
P577
2002-05-04T00:00:00Z